Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
about
Sometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptideInnate and acquired plasticity of the intestinal immune systemOntogeny of intestinal epithelial innate immune responsesStrain-specific polymorphisms in Paneth cell α-defensins of C57BL/6 mice and evidence of vestigial myeloid α-defensin pseudogenesElevated expression of Paneth cell CRS4C in ileitis-prone SAMP1/YitFc mice: regional distribution, subcellular localization, and mechanism of action.Peptidoglycan recognition proteins are a new class of human bactericidal proteins.A folding-dependent mechanism of antimicrobial peptide resistance to degradation unveiled by solution structure of distinctin.Intestinal mucus affinity and biological activity of an orally administered antibacterial and anti-inflammatory peptide.Importance of the interferon-alpha system in murine large intestine indicated by microarray analysis of commensal bacteria-induced immunological changes.Regional variations in Paneth cell antimicrobial peptide expression along the mouse intestinal tract.Manual annotation and analysis of the defensin gene cluster in the C57BL/6J mouse reference genome.Molecular modulation of intestinal epithelial barrier: contribution of microbiota.Paneth cell α-defensins in enteric innate immunityMultivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural DiversitiesRapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.The role of the immune system in regulating the microbiota.Neonatal mucosal immunology.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaNeonatal immune adaptation of the gut and its role during infections.A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions.Maturation of the enteric mucosal innate immune system during the postnatal period.Paneth cells: their role in innate immunity and inflammatory disease.Defensins and Paneth cells in inflammatory bowel disease.Clostridium difficile associated infection, diarrhea and colitisMouse Paneth cell antimicrobial function is independent of Nod2.Rattusin structure reveals a novel defensin scaffold formed by intermolecular disulfide exchanges.Roadblocks in the gut: barriers to enteric infection.Establishment of intestinal homeostasis during the neonatal period.CRS-peptides: unique defense peptides of mouse Paneth cells.Rattusin, an intestinal α-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities.Thermodynamics of RTA3 peptide binding to membranes and consequences for antimicrobial activity.Developmental switch of intestinal antimicrobial peptide expression.Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases.Dimeric unnatural polyproline-rich peptides with enhanced antibacterial activity.Salt-resistant homodimeric bactenecin, a cathelicidin-derived antimicrobial peptide.Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides.Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues.Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation.Bactericidal activity of mouse α-defensin cryptdin-4 predominantly affects noncommensal bacteria.
P2860
Q24613395-1AE3B017-B3A2-4910-A0E1-96F3C1DEC7B9Q24673019-110E61DB-C6B0-4B4D-9DAA-DD9A63B3391CQ27004090-DAB9AC66-CA1F-494B-B957-2FED2A9A1AADQ28589762-E9B4E119-5C08-4A6C-8E27-06CDAB7DE963Q28590753-218CC0CB-FB21-4A31-91AC-5218052ACA5AQ29871532-B9027894-8876-44A8-99F7-3244C838286AQ30987651-84EB5994-27CD-4D7A-B150-95DA9A9E6813Q31160852-916A1873-874A-468F-BB36-4D06FA87D667Q33331049-5C0F7A19-FE69-4B77-9C01-638BAD80B433Q33352804-67DABE3F-2C0E-44BC-96B2-48049478BBC0Q33518028-84358C84-386E-404F-9635-B0716217E6ABQ33633997-A0CE4FB5-FC3D-48C5-93BA-368B1876DDB3Q33815422-980FC2AC-3D9A-4989-8C23-1A29640A11A6Q34098551-37FF6302-9353-42A8-975A-3A0D51913C93Q34360372-4845F09D-8FC5-4327-9B90-E27E316CD496Q34503613-F44A2034-F95E-490A-80AF-71059F51DDA3Q34540798-852E31A7-49B3-4229-A167-7A584198B03DQ34647328-993C30F8-8B28-4EBA-866A-CB6253FD25CFQ34758294-45B4CC46-FDEE-4664-949A-CE805D4890BAQ35079575-978CFE14-D304-4A1A-8133-73A9BDEEACBFQ35190707-FB8BF3FB-2EB1-4718-85E7-03D9E870D8D0Q36311804-B760E0A9-5466-4298-B510-B8BB76E1F8CDQ36849133-B4E24D7D-6B19-4830-88D8-0E6A13D9AD4DQ37160538-98CF05E5-1CCD-49DE-9BD3-2F348D0FB136Q37351171-046E81D8-07AB-47CC-AD36-5583C0106D93Q37721647-7D5046CF-2D01-45C9-8476-27DAC3F25C6CQ37851576-0880467F-9E2F-443B-9668-5B8DA19A75D0Q37939633-37661A94-377F-4A8B-9942-D3989CDC1A5BQ38005595-42371370-D5F6-4E7B-95EA-28005EA5E7FFQ39766457-A7C94941-29F3-4B41-AFA6-30A18FE911A1Q40791392-04EA3F8F-E57D-4F8F-ABD2-FE3AE47D697FQ41953599-4982289C-B434-46BE-8AE7-AC77EAB54ADDQ42060877-FF86C09F-7B0C-428E-86B2-E0C6206AF469Q42111353-5842926A-D759-422C-A250-B4139DCD5F09Q42139887-41854A31-CE15-4DAC-92C5-3EDF5E3A3E25Q43958057-8AA69A68-E366-4AB3-A4BC-439B8B344CEDQ46628699-1AD49351-31BA-425D-9E6C-F2F89652C7A0Q46759429-66BB3AC5-4700-4506-AF73-F1B88669375BQ49109102-0B7EE781-6651-41A4-A86B-8936DEB21D63Q50044916-C7A135C5-27C0-4936-94D5-85504AA64390
P2860
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
description
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im August 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/08/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/08/01)
@nl
наукова стаття, опублікована в серпні 2004
@uk
مقالة علمية (نشرت في أغسطس 2004)
@ar
name
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@ast
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@en
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@nl
type
label
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@ast
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@en
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@nl
prefLabel
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@ast
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@en
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@nl
P2093
P2860
P356
P1433
P1476
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
@en
P2093
Essam Refai
Jenny Karlsson
Katrin Pütsep
Mathias W. Hornef
P2860
P304
P356
10.1038/NI1094
P407
P577
2004-08-01T00:00:00Z